Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

311
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
311
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial quality control in human ageing and longevity.

Nature metabolism·2026
Same author

Association between atrial fibrillation and systemic inflammation with muscle mass and strength trajectories in old age.

GeroScience·2026
Same author

The Gut-Muscle Axis in Sarcopenia: Mechanisms, Evidence Gaps and Translational Challenges.

Biomedicines·2026
Same author

Population Heterogeneity in Iron Biomarkers by Age, Sex, Menopausal Status, and Race in Healthy U.S. Adults: A Cross-Sectional Analysis from the All of Us Research Program.

Nutrients·2026
Same author

Access to emerging health technologies in aging: from innovation to inclusion.

The Journal of frailty & aging·2026
Same author

Inflammaging: From Mechanisms to Clinical Implications and Targeted Interventions.

Aging and disease·2026
Same journal

Exploring Neurological Disorder Therapeutics: The Progress and Future Prospects of Proteins and Peptides Derived from Blue Foods.

Current protein & peptide science·2026
Same journal

Significance of Proteomics in Cancer: Current Approaches and Trends in Biomarker Discovery.

Current protein & peptide science·2026
Same journal

Therapeutic Peptides as Targeting Vectors and Smart Therapeutics: Emerging Trends and Future Perspectives.

Current protein & peptide science·2026
Same journal

Innovative Protein Nanostructures and Hybrid Systems for Enhanced Encapsulation and Controlled Delivery of Bioactive Agents.

Current protein & peptide science·2026
Same journal

Nanotherapeutic Interventions in Diabetic Wound Healing: Biomarker- Guided Mechanisms and Translational Prospects.

Current protein & peptide science·2026
Same journal

Recent developments in intein-mediated protein splicing and their applications in bioengineering.

Current protein & peptide science·2026
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.9K

Biomarkers for Sarcopenia: Reductionism vs. Complexity.

Riccardo Calvani1, Anna Picca1, Matteo Cesari2,3

  • 1Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy.

Current Protein & Peptide Science
|May 20, 2017
PubMed
Summary
This summary is machine-generated.

Sarcopenia, a muscle loss issue in older adults, lacks a clear definition, hindering biomarker discovery. This review explores new multivariate methods for identifying effective sarcopenia biomarkers.

Keywords:
Frailtydisabilitymarkersmultivariate analysisphysical performanceskeletal muscle.

More Related Videos

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 2, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.9K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.4K

Area of Science:

  • Gerontology
  • Muscle Physiology
  • Biomarker Discovery

Background:

  • Sarcopenia is a significant health concern in older adults, characterized by muscle mass and strength decline.
  • Its high prevalence and clinical impact are often underestimated due to a lack of a unified definition.
  • Identifying reliable biomarkers for sarcopenia is challenging due to the complexity of musculoskeletal aging.

Purpose of the Study:

  • To review current knowledge on biological markers for sarcopenia.
  • To critically evaluate traditional biomarker development approaches in muscle aging.
  • To present multivariate methodologies as a promising alternative for biomarker discovery.

Main Methods:

  • Literature review of sarcopenia and biomarker research.
  • Critical appraisal of conventional biomarker identification techniques.
  • Illustration of multivariate approaches for multidimensional biomarker modeling.

Main Results:

  • The absence of a standardized sarcopenia definition complicates biomarker validation.
  • Traditional methods face challenges in capturing the multifactorial nature of sarcopenia.
  • Multivariate modeling offers a more comprehensive approach to identifying clinically relevant biomarkers.

Conclusions:

  • Developing effective sarcopenia biomarkers requires addressing definitional ambiguities.
  • Multivariate methodologies show significant potential for advancing sarcopenia biomarker discovery.
  • These advanced approaches can enhance clinical and research applications in understanding muscle aging.